Related Experiment Video
Updated: Jul 10, 2026
06:47
Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique
Published on: September 20, 2011
Physically bonded nanoparticle networks: a novel drug delivery system
Xiaohu Xia1, Zhibing Hu, Manuel Marquez
1Department of Physics, University of North Texas, Denton, TX 76203, USA.
Summary
This study developed injectable polymer nanoparticles for controlled drug delivery. These nanoparticles form a gel at body temperature, enabling sustained release of macromolecular drugs from an in situ depot.
Area of Science:
- Materials Science
- Polymer Chemistry
- Biomedical Engineering
Background:
- Developing injectable drug delivery systems is crucial for sustained therapeutic agent release.
- Interpenetrating polymer networks (IPNs) offer tunable properties for advanced material applications.
- Thermoresponsive polymers enable stimuli-responsive drug delivery systems.
Purpose of the Study:
- To synthesize and characterize monodispersed IPN nanoparticles for injectable drug delivery.
- To investigate the inverse thermoreversible gelation behavior of these nanoparticles.
- To evaluate the drug release profiles from the in situ formed gel depot.
Main Methods:
- Seed-and-feed method for nanoparticle synthesis.
- Temperature-dependent viscosity measurements to determine gelation point.
- UV-Visible spectroscopy to quantify drug release kinetics.
Main Results:
- Monodispersed IPN nanoparticles of PAAc and PNIPAM were successfully prepared.
- Dispersions exhibited inverse thermoreversible gelation above 2.5 wt.% at approximately 33°C.
- Drug release was modulated by nanoparticle size and polymer concentration, demonstrating controlled release from the gel depot.
Conclusions:
- The synthesized IPN nanoparticles form injectable liquids that gel in situ at body temperature.
- This system provides a promising platform for sustained release of macromolecular drugs.
- The non-reactive mixing at room temperature simplifies formulation and administration.
Related Concept Videos
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...